Trial intelligence / Profile preview

Intracervical hyoscine for cervical dilation in women with cervical stenosis during hysteroscopy

IRCT20220703055355N1Phase 3Completed

Sponsor
Guilan University of Medical Sciences
Start
Jul 2022
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of scopolamine in cervical spinal stenosis (CSS) (2 arms), sponsored by Guilan University of Medical Sciences. Started Jul 2022; status: completed.

02

Drugs

scopolamine
03

Conditions

cervical spinal stenosis (CSS)

Beyond the preview

Go deeper on IRCT20220703055355N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220703055355N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call